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Background: The replication of simian foamy virus from macaques can be inhibited by the nucleoside reverse
transcriptase inhibitor azidothymidine (AZT, zidovudine). Four substitutions in the protease-reverse transcriptase
(PR-RT) protein (K211I, I224T, S345T, E350K) are necessary to obtain highly AZT resistant and fully replication
competent virus. AZT resistance is based on the excision of the incorporated AZTMP in the presence of ATP. I224T
is a polymorphism which is not essential for AZT resistance per se, but is important for regaining efficient replication
of the resistant virus.
Results: We constructed PR-RT enzymes harboring one to four amino acid substitutions to analyze them biochemically
and to determine their ability to remove the incorporated AZTMP. S345T is the only single substitution variant
exhibiting significant AZTMP excision activity. Although K211I alone showed no AZTMP excision activity, excision
efficiency doubled when K211I was present in combination with S345T and E350K. K211I also decreased nucleotide
binding affinity and increased fidelity. NMR titration experiments revealed that a truncated version of the highly AZT
resistant mt4 variant, comprising only the fingers-palm subdomains was able to bind ATP with a KD-value of ca.
7.6 mM, whereas no ATP binding could be detected in the corresponding wild type protein. We could show by NMR
spectroscopy that S345T is responsible for ATP binding, probably by making a tryptophan residue accessible.
Conclusion: Although AZT resistance in SFVmac is based on excision of the incorporated AZTMP like in HIV-1, the
functions of the resistance substitutions in SFVmac PR-RT appear to be different. No mutation resulting in an
aromatic residue like F/Y215 in HIV, which is responsible for π-π-stacking interactions with ATP, is present in
SFVmac. Instead, S345T is responsible for creating an ATP binding site, probably by making an already existing
tryptophan more accessible, which in turn can interact with ATP. This is in contrast to HIV-1 RT, in which an ATP
binding site is present in the WT RT but differs from that of the AZT resistant enzyme.
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Simian foamy virus from macaques (SFVmac) belongs to
the subfamily of Spumaretrovirinae, which, together
with the Orthoretrovirinae form the family of Retroviri-
dae [1]. A considerable difference between the two sub-
families concerns the nature of the cleavage products of
the Pol protein, which consists of the protease (PR),
reverse transcriptase (RT) and integrase (IN) domains.
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unless otherwise stated.from a Gag-Pol precursor protein into PR, RT and IN,
foamy viruses (FVs) possess a separate Pol precursor and
do not cleave off the PR domain from the RT. Thus, the
mature FV enzymes are PR-RT and IN [2,3]. The mature
PR-RT is a monomeric protein with the PR (101 amino
acid residues) located at its N-terminus [3]. The PR is
separated from the putative N-terminus of the RT do-
main via a stretch of 41 amino acid residues (region
102–143) whose presence appears to be important for
RT integrity and proper orientation of the PR domain,
which needs to dimerize in order to be active [4-7].
So far, only the human immunodeficiency (HIV)
nucleotide RT inhibitor (NtRTI) tenofovir and theral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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zidovudine) have been shown to inhibit SFVmac replica-
tion [8-11]. Both substances are used for treating
patients suffering from HIV infections.
Interestingly, both SFVmac and HIV-1 RT follow a
similar AZT resistance mechanism: the incorporated
chain terminating AZT-monophosphate (AZTMP) is ex-
cised in the presence of ATP [12-14]. It has been shown
that the pyrophosphate donor in AZT resistant HIV-1
and SFVmac is ATP [12-14]. In HIV-1, the excision re-
action products are a dinucleoside tetraphosphate (AZT-
P4-A) derived from ATP and AZTMP at the primer
terminus and the resulting unblocked 3’OH primer [12].
Formation of the phosphodiester bond between ATP
and AZTMP also requires specific ATP binding near the
polymerase active site which orients the β,γ-phosphate
moiety of ATP proximal to the phosphate group of
AZTMP. Removal of AZTMP finally leads to primer res-
cue and elongation with natural dNTPs [15-17].
In SFVmac PR-RT four amino acid exchanges (K211I,
I224T, S345T, E350K) are necessary to confer high re-
sistance against AZT. Amino acid sequence alignments
of the polymerase domains of SFVmac and HIV-1 re-
vealed that the SFVmac AZT resistance mutations do
not correspond to the ones obtained with highly AZT-
resistant HIV-1 RT (M41L, D67N, K70R, T215Y/F and
K219Q/E) [12-14,17-21]. In HIV-1 the amino acid ex-
change T215Y/F is crucial for binding of ATP in the
AZT resistant mutant RT. X-ray crystallography data re-
vealed that both the WT and the AZT resistant RT are
capable of ATP binding, however at different sites (site I
and site II). The aromatic amino acid exchange T215F/Y in
the resistant protein allows binding of ATP in site II and
the formation of π-π stacking interactions with the adenine
ring of ATP, necessary for AZTMP excision [15,17].
Comparison of the AZT resistance mutations selected
in HIV-1 and SFVmac shows that in SFVmac no exchange
to an aromatic amino acid homologous to T215Y/F oc-
curs. This raises the question as to what the functions of
the individual mutations in the AZT resistant SFVmac RT
are. We have shown previously that the amino acid
exchange I224T is important for viral fitness but not
for AZT resistance per se, i.e. it is not required for the
AZTMP excision reaction [11,14].
Comparative studies on AZT resistance in ortho- and
spumaretroviruses can shed light on the general require-
ments for AZTMP excision. HIV-1 and SFVmac achieve
AZT resistance by AZTMP excision using different,
non-homologous resistance pathways. In order to dis-
close the functions of the individual mutations for AZT
resistance and the molecular mechanism in SFVmac PR-
RT, we characterized the biochemical properties of vari-
ous PR-RT variants harboring single, double, triple, and
quadruple amino acid substitutions and analyzed theability of the variants to excise AZTMP. Moreover, we
examined ATP binding via NMR spectroscopy.
Here, we determined for the first time the molecular
mechanism for AZT resistance in a monomeric RT as
well as the dissociation constant for ATP in an AZT re-
sistant retroviral RT.
Results and discussion
Protein variants
We have shown previously that the purified SFVmac
PR-RTs mt3 (K211I, S345K, E350K) and mt4 (K211I,
I224T, S345K, E350K) are able to excise AZTMP with
similar efficiency from an AZTMP-terminated primer in
the presence of ATP [14]. The I224T exchange in mt4 is
probably a polymorphism and does not contribute sub-
stantially to AZT-resistance but to viral fitness [11,14].
To reveal the individual contribution of the amino acid
exchanges in SFVmac PR-RT for AZT resistance we ana-
lyzed various PR-RT enzymes with one to four amino
acid substitutions in the polymerase domain. Addition-
ally, all PR-RT enzymes used, carry a mutation in the PR
domain leading to the active site residue exchange
D24A. This renders the enzymes inactive as a protease.
Thus, unintentional PR cleavage can be excluded.
RTs and several other DNA polymerases share a com-
mon three-dimensional structure, which is usually com-
pared to the shape of a right hand with the so-called
fingers, thumb, and palm subdomains [22-24]. The ac-
tive site residues are located in the palm, while the
thumb and fingers regions wrap around the nucleic acid
substrate. Thus, the putative localization of the four ex-
changed amino acids in AZT resistant SFVmac PR-RT
with regard to the polymerase active site could be deter-
mined by modeling the structure of the SFVmac poly-
merase domain with the Program SWISS-MODEL [25]
using xenotropic murine leukemia-like related virus
(XMRV) RT (pdb: 4HKQ) with a sequence homology of
approximately 29 % as a template [22] (Figure 1). Simi-
larly to SFVmac PR-RT this enzyme is also monomeric.
The model shows that the polymorphism I224T is lo-
cated at some distance to the active site residues YVDD,
while S345T and E350K are positioned in the palm sub-
domain next to the active site and thus could be in-
volved in ATP-binding. K211I is part of a loop in the
fingers subdomain, homologous to the beta β3-β4 loop
in HIV-1 RT. In HIV-1 RT this loop contains the basic
amino acids K65 and R72 that interact with the phos-
phates of an incoming dNTP. These residues have been
shown to be important for polymerization activity, drug
resistance, and fidelity [26,27].
Polymerization properties
To show that the purified recombinant proteins harbor-
ing one to four amino acid exchanges (Figure 2A) were
Figure 1 Localization of the AZT resistance substitutions. The
putative locations of the four substituted amino acid residues in
the highly resistant mt4 (I211, T224, T345, K350) are highlighted in
red in a structural model of the SFVmac RT polymerase domain. The
polymerase active site motif YVDD is highlighted in blue. The model
is based on the structure of XMRV RT (PDB: 4HKQ) with an RNA/DNA
hybrid substrate and was generated using the Program
SWISS-MODEL [25].
Figure 2 Polymerization activity and AZT resistance of SFVmac PR-RT
to four of the relevant resistance substitutions are highlighted by red recta
checked with 20 nM 5′ 32P-P30/T50 substrate, 250 μM dNTPs and 10 nM enz
gel. WT, wild type; Control, sample without enzyme. (C) AZTMP removal in
substrate P30-AZTMP/T50, 0.02 U of pyrophosphatase and 5 mM ATP were pre
nM enzyme as indicated on top and stopped after 20 min. Reaction produ
phosphoimaging. P30-AZT, AZTMP terminated primer; P30, unblocked primer
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acitvities on a poly(rA)/oligo(dT) substrate (Table 1). Obvi-
ously, the K211I exchange results in severely reduced
polymerization activity since the single as well as the double
variants harboring K211I (mt2a, mt2b) are impaired. In
contrast, mt2c lacking K211I exhibits high polymerization
activity. Remarkably, the specific polymerization activity of
E350K is significantly higher than that of the WT.
Since the specific activities of the variants containing
K211I were considerably lower than the WT activities,
we performed primer extension assays with a 30/50mer
DNA/DNA (P30/T50) substrate which was 5′
32P endla-
beled at the primer. Conditions were chosen that
allowed the investigation of the first nucleotide addition
steps (Figure 2B) to determine whether the enzymes are
impaired in initiating polymerization. Although all pro-
teins were able to extend the primer by a few nucleo-
tides, K211I appeared to be the least active enzyme
among the single exchange variants. Accordingly, mt2a
and mt2b, also harboring the K211I substitution, were
less efficient in initiating polymerization than mt2c. The
latter shows an even higher activity than the WT. These
data are also reflected in the specific polymerization ac-
tivities measured with the homopolymeric substrate poly
(rA)/oligo(dT) (Table 1). Interestingly, due to the pres-
ence of K211I, the activity of mt3 is reduced as com-
pared to the WT. However, the polymerization behavior
of mt4 is again comparable to the WT owing to the
presence of the polymorphism I224T.
AZT resistance
AZT resistance in SFVmac is based on the removal of
the incorporated AZTMP in the presence of ATP [14].
Therefore, to elucidate the function of the individualvariants. (A). SFVmac PR-RT variants used in this study harboring one
ngles. (B) Polymerization initiation. Initiation of polymerization was
yme at 37°C for 10 min. The PR-RTs used are indicated on top of the
the presence of ATP. 5 nM of an AZTMP-terminated and 5′ 32P-labeled
incubated for 5 min. Reactions were started by the addition of 320
cts were separated on 10% sequencing gels and visualized by
.
Table 1 Specific polymerization activities and AZT resistance of SFVmac PR-RTs and corresponding viruses
Enzyme 1SPAC p-value 2AZTMP
excision
(%)
3Viral titer in %
w/o AZT 5 μM AZT
WT 28.6 (±3.1) - 3.0 (±1.1) 100 <0.1
K211I 7.0 (±4.8) 0.005 2.4 (±1.4) 1.2 (±1.2) <0.1
I224T 22.5 (±10.3) 0.410 3.5 (±1.4) 146.5 (±21.4) 0.1
S345T 28.8 (±8.3) 0.977 10.4 (±1.2) 40.0 (±16.8) 1.1 (±1.0)
E350K 44.7 (±2.1) 0.003 2.8 (±0.7) 31.7 (±8.8) <0.1
mt2a 13.3 (±0.9) 0.009 14.5 (±0.7) <0.1 <0.1
mt2b 8.7 (±2.9) 0.001 7.9 (±0.6) 23.0 (±7.9) <0.1
mt2c 32.6 (±13.8) 0.667 18.7 (±1.2) 20.6 (±5.5) 3.0 (±2.1)
mt3 15.5 (±2.6) 0.005 35.4 (±0.6) 8.6 (±2.7) 2.8 (±1.3)
mt4 21.7 (±3.9) 0.079 37.9 (±1.3) 113.0 (±19.2) 68.8 (±18.8)
1SPAC, specific activity in U/10 min*μgprotein. One Unit (U) catalyzes the incorporation of 1 nmol TTP in a poly(rA)/oligo(dT)15 in 10 min at 37°C by 1 μg PR-RT.
The values are the means and standard deviations of at least three independent experiments. The p-values were calculated using the unpaired t-test in which
we compared each variant with the WT. p-values ≤0.05 are considered significant. 2Quantification of AZTMP removal depicted in Figure 2C was achieved by
phosphoimaging. The amount of unblocked primer after AZTMP excision (P30) is equivalent to the quantity of excised AZTMP and is given as a percentage of
the total amount of primer in the reaction. 3Data taken from [11]. The viral titers in the cell free supernatants of the WT in the absence of AZT were set to 100%
(≙ viral titer of 7 x 104). Titers of mutant viruses are expressed relative to the WT. Standard errors are given in parenthesis.
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cision efficiency using a 5’ 32P-endlabeled and AZTMP-
terminated primer/template substrate (P30-AZT/T50) and
5 mM ATP (Figure 2C, Table 1). Only one of the singly
substituted variants, i.e. S345T, showed significant (>5%)
AZTMP excision activity. This indicates that S345T is the
key amino acid exchange for AZTMP removal. As shown
above, the inability of the other single variants to remove
incorporated AZTMP is not due to a lack of polymerization
activity (Table 1, Figure 2B). We have shown previously that
the single amino acid exchange S345T leads to moderate
drug resistance of the virus in the presence of 0.5 – 5 μM
AZT. However, in the absence of AZT it resulted in re-
duced viral titer (40%) as compared to the WT virus [11]
(Table 1).
Among the enzyme variants carrying two substitu-
tions, a combination of the key exchange S345T with
K211I (mt2a) improved the excision efficiency as com-
pared to S345T alone from ca. 10 to 15%, and the com-
bination of S345T with E350K (mt2c) almost doubled
the excision efficiency (ca. 19%) (Table 1). In contrast,
mt2b, lacking the S345T substitution, exhibited no sig-
nificant AZTMP removal activity.
Remarkably, the virus harboring the corresponding
substitutions of mt2a was not able to replicate, neither
in the presence nor in the absence of AZT, although the
purified PR-RT variant still showed polymerization activ-
ity, albeit reduced (Figure 2B). Virus mt2c exhibited
moderate AZT resistance, but in the absence of AZT the
viral fitness was reduced to ca. 20% as compared to the
WT virus [11] (Table 1). These data imply that E350K
might be the second AZT resistance mutation, since the
combination of the putative first exchange S345T withK211I leads to replication deficient virus (Table 1). The
combination of K211I and E350K (mt2b) showed little
AZTMP excision in vitro. This was reflected in cell cul-
ture assays with the corresponding virus, which was un-
able to replicate in the presence of 5 μM AZT [11]
(Table 1). Obviously, the K211I exchange on its own and
in mt2a yields replication deficient virus (Figure 2B,
Table 1) [11]. However, in mt3 the presence of K211I
supported AZTMP removal. Compared to mt2c, the ex-
cision efficiency of mt3 was about 2-fold higher (Table 1).
Moreover, the high excision activity was retained with
mt4, confirming that I224T improves viral fitness in the
fully resistant virus but is not involved in AZT resistance
per se. This was also illustrated by the fact that the dra-
matic decrease of viral titer with the mt3 virus (8.6% of
the WT virus) in the absence of AZT was fully compen-
sated by I224T in the mt4 virus, bringing the titer back
to WT levels (ca. 113%) (Table 1) [11].
Taken together, these data show that the single substi-
tution S345T results in moderate ATZMP excision activ-
ity, which can be further improved in combination with
K211I or E350K. The major gain in AZTMP excision ef-
ficiency is due to the additional exchange K211I. How-
ever, this substitution leads to an impaired polymerization
reaction, which can be recovered in mt4 by I224T.
RNase H activities
In HIV-1 RT certain substitutions in the connection sub-
domain or RNase H domain leading to a reduced RNase
H activity can enhance AZT resistance on a DNA/RNA
primer/template. Slowing down the RNase H activity al-
lows the enzyme more time for AZTMP excision to take
place [28-30]. To investigate whether the substitutions
Table 2 Kinetic parameters of SFVmac PR-RTs for
polymerization and DNA binding
Enzyme 1KM (μM)
1Vmax
(mM/min)
Vmax/KM
(1/min)
2KD P/T
(nM)
WT 57 (±7) 2.1 (±0.08) 36.8 (±4.7) 9.6 (±0.7)
K211I 160 (±28) 0.3 (±0.02) 1.9 (±0.4) 19.6 (±2.3)
I224T 94 (±9) 2.2 (±0.08) 23.4 (±2.4) 8.9 (±1.4)
S345T 34 (±6) 1.1 (±0.05) 32.4 (±5.9) 8.7 (±0.9)
E350K 32 (±8) 1.8 (±0.10) 56.3 (±14.4) 9.7 (±1.7)
mt2a 252 (±39) 0.5 (±0.04) 2.0 (±0.3) 7.8 (±1.2)
mt2b 159 (±41) 0.6 (±0.02) 3.8 (±1.0) 15.8 (±2.5)
mt2c 9 (±3) 2.5 (±0.10) 277.8 (±92.6) 17.2 (±2.1)
mt3 67 (±14) 2.0 (±0.10) 29.9 (±6.2) 15.8 (±2.1)
mt4 110 (±11) 1.3 (±0.05) 11.8 (±1.3) 9.5 (±1.6)
1
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domain or RNase H domain, influence the RNase H ac-
tivity, we performed qualitative RNase H assays with a 5’
32P-endlabeled RNA25/DNA22 substrate (Figure 3). How-
ever, no significant reduction of the RNase H activities
could be detected. Rather, quantification of the cleavage
products indicated that E350K exhibits a significantly
higher RNase H activity than all the other enzymes.
Apart from this effect no significant differences, e.g. in
the cleavage pattern, could be detected, implying no in-
fluence of the RNase H activity on AZT resistance.
Kinetic parameters for polymerization and DNA binding
To further assess the effect of the K211I substitution on
AZT resistance, we determined the kinetic parameters
of the enzymes (Table 2). The reduced polymerizationFigure 3 Qualitative RNase H assay. (A) Schematic representation
of the 5′ 32P-RNA25/DNA22 hybrid. The arrows on top of the RNA
indicate the major RNase H cleavage sites at position −17 and −18.
The first nucleotide of the RNA hybridized to the 3′-OH nucleotide
of the DNA strand is designated −1. (B) Quantification of the RNase
H cleavage products. The diagram depicts the mean values and
standard deviations (black bars) of three independent experiments. For
quantification of the cleavage products the total amount of labeled
RNA per lane was set to 100%. Only the p-value of E350K≤ 0.01 (**)
represents a statistically significant difference to the WT protein. (C)
Autoradiogram of a typical RNase H cleavage experiment. RNase H
reactions were performed with 240 nM 5′ 32P-RNA25/DNA22 hybrid
and 50 nM RT-PR for 2 min at 25°C. RNA T25, uncleaved RNA; −17, 18
indicate the cleavage sites; control, reaction mix without enzyme.
KM- and vmax-values were obtained by using the Michaelis-Menten equation
to fit a curve to the data. 2KD-values were obtained as described previously
[14] by using an equation for a two state model to fit a curve to the titration
data. Standard errors are given in parenthesis.activity of variant K211I might be due to changes in af-
finities for the nucleic acid substrate and/or the dNTP.
Determination of KM- and vmax-values as well as the
vmax/KM ratio for nucleotide incorporation points in this
direction. KM-values of K211I and variants harboring
K211I (mt2b and mt2a) were about 3-fold (mt2b) or
5-fold (mt2a) higher than that of the WT enzyme. In
contrast, WT vmax values are about 4- to 7-fold higher.
E350K and mt2c reach higher vmax/KM-values than the
WT, indicating higher catalytic activities (Table 2). How-
ever, this effect was obliterated by the introduction of
K211I. The activity of the resulting mt3 was again simi-
lar to the WT.
Fluorescence anisotropy measurements with a fluo-
rescent labeled DNA/DNA P/T resulted in similar
KD-values for all enzymes (Table 2). These findings con-
firm that K211I leads to an impairment of polymerization
activity due to a decrease in nucleotide binding affinity,
but not by altering the P/T binding affinity. Furthermore,
substitution E350K and I224T appear to compensate the
polymerization deficiency of K211I in the mt3 variant as
well as in the highly resistant mt4 protein.
Fidelity
The basic amino acid residues K65 und R72 in the β3-
β4 loop region of the HIV-1 RT fingers subdomain not
only have an impact on nucleotide binding affinity, but
also on fidelity [26,27,31]. The fidelity of a polymerase
describes the accuracy of nucleotide incorporation.
Therefore, we investigated whether K211I, which is also
positioned in the fingers subdomain, alters the SFVmac
PR-RT’s fidelity. We used a DNA/DNA P30/T50dA sub-
strate labeled at the 5’ end of the primer to determine
how efficient the primer can be elongated with a
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(Figure 4A). To overcome the reduced nucleotide bind-
ing affinity caused by K211I, a 5-fold higher nucleotide
concentration than in the polymerization assay was used
for all enzymes.
In the presence of the complementary dTTP all en-
zymes extended the primer by one nucleotide with simi-
lar efficiency (Figure 4B, Additional file 1: Table S1),
whereas additional nucleotide incorporations were due
to mismatch events. In contrast, when non-templated
dATP was used, primer extensions varied considerably
(Figure 4C). Quantification of the extended primer after
misincorporation disclosed that variant K211I, as well as
mt2a and mt2b, also harboring the K211I exchange, ex-
hibited a significantly higher fidelity than the other en-
zymes, i.e. reduced incorporation efficiency for the
mismatched dATP. mt2c, lacking the K211I substitution,
showed a behavior similar to the WT enzyme (Figure 4C,
Additional file 1: Table S1). In mt3, S345T and E350K
appear to compensate the effect of K211I, since mt3, al-
though containing the K211I exchange exhibited WT fi-
delity. Due to a decreased binding affinity for all dNTPs
in enzymes harboring K211I, dissociation of the incor-
rect nucleotide and thereby correct base pairing is facili-
tated. This is similar to the results shown with the
substitutions K65R and M184V/I in HIV-1 RT revealing
an inverse correlation between fidelity and processivity
or activity of the RT [26,27,32-35].
In mt3 the reduced viral fitness of K211I is improved
by S345T and E350K (Table 1), whereas the impaired fi-
delity caused by S345T and E350K is counteracted by
K211I (Figure 4C). However, in order to restore viral fit-
ness completely, the additional exchange I224T, resulting
in mt4, is required. Thus, some of the mutations in AZT
resistant SFVmac RT mt4 are not absolutely required for
AZTMP removal but compensate the negative effects of
the substitutions crucial for resistance.
ATP binding analysis
Interactions of proteins with ligands, e.g. ATP, can be
investigated by NMR spectroscopy. An NMR spectrum
of a 15N labeled protein, which correlates resonance
frequencies of amide protons and directly bonded 15N
labeled nitrogen atoms (2D [1H-15N] HSQC, heteronuc-
lear single quantum correlation) allows the individual
detection of peptide amide signals in the protein. Each
signal represents a single amino acid of the peptide
chain. Chemical shifts are very sensitive to the local
structure of the protein. Changes in the chemical envir-
onment of amino acids, e.g. due to ATP binding, lead to
chemical shift changes in the spectrum which indicate
interactions between the protein and ATP.
Analysis of large proteins by NMR is limited due to
extensive signal overlaps and a severe reduction in signalintensity. To obtain an RT small enough and suitable for
NMR analysis, we constructed a truncated SFVmac
polymerase domain lacking the thumb but comprising
the fingers and palm subdomains that contain all four
amino acid substitutions for AZT resistance. In previous
work, we have already determined the starting point of
the RT domain at residue 107 of the PR-RT enzyme. De-
letion of the PR at that residue provides a soluble and
catalytically active RT [4]. Based on sequence alignments
with a catalytic fragment of Moloney murine leukemia
virus (MoMLV) RT [36], the corresponding region of
SFVmac RT harboring amino acid residues 107–368
(RTshort) was constructed. Determination of its specific
activity for polymerization on poly(rA)/oligo(dT) indi-
cated a very low polymerization activity (0.83 U), how-
ever, the protein was still able to bind double stranded
DNA, albeit with a ca. 100 fold higher KD-value (3.6 ±
0.5 μM) than the WT enzyme [3]. The 1H/15N-HSQC of
RTshort-WT recorded in the absence and presence of
21 mM ATP (58 fold excess) revealed no significant
chemical shift changes upon ATP addition (Figure 5A),
indicating lack of ATP binding, although the concen-
tration is far beyond published physiological values
of < 10 mM [37-39].
However, with AZT resistant RTshort-mt4 several
significant chemical shift changes upon ATP addition
(48-fold excess) could be observed, demonstrating ATP
binding. Since S345T is the only single amino acid ex-
change exhibiting AZTMP excision activity (Figure 2C),
we reversed the S345T exchange in RTshort-mt4 back to
WT (=RTshort-mt4-T345S) and recorded 1H/15N-HSQC
spectra in the absence and presence of ATP (Figure 5C).
Even at a 59-fold excess of ATP no chemical shift
changes were detectable in the spectrum of RTshort-
mt4-T345S. This result indicates a key role of the S345T
substitution in AZT resistance via creating an ATP binding
pocket, which is necessary for the excision mechanism.
Assignment of protein backbone resonances by
TROSY-based triple resonance NMR analyses using a
2H/15N/13C labeled RTshort-mt4 sample failed due to in-
sufficient sample stability (precipitation) over the course
of the experiments. Using the initially recorded HNCA
experiment together with known chemical shift regions,
the 1H chemical shift signals between 10.0 and 10.5 ppm
in the 1H/15N HSQC spectrum could be identified as
tryptophan residues (indol-NH resonances). Typically,
the indol-NH-resonances are located in the chemical
shift range between 9.5 and 10.5 ppm [40,41]. Compari-
son of the spectra (Figure 5, boxes a) proves that a Trp
residue is involved in ATP binding in RTshort-mt4, since
a chemical shift change is detectable in the relevant
ppm-range (Figure 5B, box a). Obviously, this Trp resi-
due is obscured in RTshort-WT as well as in RTshort-
mt4-T345S. The chemical shift change of a Trp residue
Figure 4 (See legend on next page.)
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Figure 4 Fidelity of PR-RTs. 20 nM of a 5′ 32P endlabeled P30/T50dA DNA/DNA substrate was incubated with 1.25 mM of the correct (dTTP) or
incorrect (dATP) nucleotide for polymerization. Reaction products were separated on a 10% sequencing gel. (A) Schematic representation of
primer extension with the correct nucleotide and primer extension after one nucleotide mismatch. (B) Primer extensions in the presence of the
next templated nucleotide (dTTP). Control, assay without enzyme. The diagram (top) depicts the mean values and standard deviations (black bars)
of three independent experiments. The autoradiogram (bottom) shows the result of a typical extension experiment. The length of the extensions
(P31 to P35) is indicated on the left. Since the bands above P31 all comprise the first correct dTTP incorporation they were also included in quantification
of the primer extension. For quantification of the extended products the total amount of labeled DNA per lane was set to 100%. (C) Mismatch primer
extensions in the presence of a non-templated nucleotide (dATP). Evaluation of the results as in (B). P-values≤ 0.05 represent statistically significant
differences to the WT protein (* p-value≤ 0.05; ** p-value≤ 0.01;*** p-value≤ 0.001).
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π interactions, very similar to the interactions between
ATP and F/Y215 in HIV-1 RT [15]. In the highly AZT
resistant SFVmac PR-RT the substitution S345T might
alter the surface exposed residues in its vicinity and thus
makes a Trp residue more accessible for hydrophobic in-
teractions with ATP. In contrast to HIV-1 RT, AZT re-
sistance substitutions in SFVmac PR-RT do not result in
an aromatic amino acid, but instead make an already ex-
istent Trp accessible to fulfill a similar task as the
T215Y/F exchange in HIV-1 RT.
Dissociation constant for ATP binding
To assess the KD-value for ATP binding in RTshort-mt4
we needed to improve the quality of the spectra. There-
fore, RTshort-mt4 was deuterated in addition to 15N la-
beling to allow the recording of TROSY 1H/15N-HSQC
spectra (Figure 6A). Application of this technique resulted
in sharper NMR signals owing to reduced transverse re-
laxation and rendered faster recording of the spectra pos-
sible. Thus, sample stability problems, i.e. precipitation
during NMR measurements, could be overcome.
In a series of 1H, 15N correlation experiments with in-
creasing ATP concentrations, several signals showed the
typical gradual change of chemical shifts observed for
fast chemical exchange on the NMR time scale. The ac-
tual chemical shift in such a spectrum represents the
population average of the signal frequencies in the free
and bound state, allowing the determination of the dis-
sociation constant in a series of titration experiments.
The average KD-value for ATP from seven shifting
signals in the HSQC spectrum was 7.6 (±2.4) mM.
(Figure 5B). This KD-value is in the range of published
physiological concentrations for ATP in the low millimo-
lar range [37-39].
To analyze how the resistance substitutions alter the
ATP binding affinity in the full-length PR-RT enzymes
we determined KM- and vmax-values for ATP using vary-
ing ATP concentrations in AZTMP excision assays
(Table 3). The kinetic parameters were only defined for
those enzyme variants capable of excising AZTMP in
the presence of ATP (Figure 2C). While KM-values for
S345T, mt2a and mt2c were comparable, significantly
lower KM-values were measured with mt3 and mt4,again indicating that the combination of the three ex-
changes K211I, S345T and E350K is necessary for high
affinity ATP binding and thus for efficient AZTMP
removal.
Conclusions
We were able to assign different functions to the resi-
dues in SFVmac RT responsible for AZT resistance.
S345T is probably the first exchange since it is the only
single amino acid exchange conferring moderate AZT
resistance. Thus, S345T is essential for AZT resistance.
It appears to make a Trp residue in the palm subdomain
accessible for ATP binding by π-π stacking interactions
of the aromatic rings, thus establishing a new ATP bind-
ing site in the enzyme variant that does not exist in the
WT. Figure 7 shows a model of SFVmac RT mt4
highlighting the localization of the seven Trp residues
that are present in the fingers and palm subdomains.
The spacefilling representation (Figure 7B) indicates that
most of the Trp residues are located in the inner core of
the enzyme and thus do not come into consideration for
ATP binding. However, residue W258 is close enough to
the active site as well as to the essential residue T345.
Furthermore, it is not positioned in the enzyme’s interior
and thus might be the Trp residue qualifiying for ATP
binding. Our results are in strong contrast to AZT-
resistant HIV-1 RT, in which a second ATP binding site is
created in the enzyme (site II) ca. 10 Å away from site I,
by introducing the aromatic substitution T215F/Y [15-17].
In SFVmac RT the substitution E350K improves the
catalytic efficiency of dNTP incorporation, thereby com-
pensating the reduced polymerization activity caused by
K211I in mt3 and mt4. K211I increases fidelity by redu-
cing dNTP affinity, thus facilitating dissociation of a
non-complementary dNTP.
The KD-value for ATP of RTshort-mt4, harboring the
new ATP binding site, is ca. 7.6 mM. This is in good
agreement with published cellular ATP concentrations
[37-39] and the ATP concentration (5 mM) we success-
fully used for in vitro AZTMP excision experiments. In
HIV-1, the binding sites for ATP and the incoming
dNTP overlap [15,42]. Obviously, the affinity for ATP
needs to be lower than that for the dNTP since other-
wise ATP binding would inhibit polymerization in the
Figure 5 HSQC spectra of RTshort-WT, RTshort-mt4 and RTshort-mt4-T345S. Overlays of 1H/15N-HSQC spectra of RTshort proteins in the
absence of ATP (black) and in the presence of 21 mM ATP (red) in binding buffer with 10% D2O at a sample temperature of 298 K. (A) black:
460 μM RTshort-WT without ATP; red: 363 μM RTshort-WT with a 58 fold ATP excess. (B) black: 550 μM RTshort-mt4 without ATP; red: 434 μM
RTshort with a 48 fold ATP excess. (C) black: RTshort-mt4-T345S without ATP; red: 355 μM RTshort-mt4-T345S with a 59 fold ATP excess
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achieved when AZTMP is incorporated due to pausing of
the RT in the so-called pre-translocation complex in which
the binding pocket for the dNTP is not accessible [16].In addition to ATP binding, the excision mechanism
further requires formation of a phosphodiester bond be-
tween ATP and the incorporated AZTMP, followed by the
dissociation of the putative excision product, dinucleoside
Figure 6 Titration of RTshort-mt4 with ATP. (A) Overlay of
TROSY-1H/15N-HSQC spectra of 205 μM RTshort-mt4 recorded at a
sample temperature of 288 K during the titration with different ATP/
protein ratios. Key: black: 0; red: 15; green: 48; cyan: 92; blue: 142;
pink: 195. Blow-ups of the framed areas (a) and (b) are shown
underneath the spectra and represent examples of significant
chemical shift changes with RTshort-mt4 and ATP. (B) Determination
of the mean KD-value for ATP with RTshort-mt4. Seven fits for
normalized chemical shift changes of seven shifting residues
encircled in (A) were used to calculate the mean KD-value with
standard deviation. Exemplified, fitted curves for three signal
changes depicted in boxes (a) and (b) are shown as a function of
the [ATP]/[RTshort-mt4] ratio.
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ity for nucleotides K211I might facilitate the dissociation
of the AZT-P4-A, thereby improving the excision reaction
in the presence of S345T. Moreover, K211I reduces viral
fitness which is at least in part due to the impaired
polymerization activity. This, in turn, is compensated by
I224T, which improves viral fitness but is not directly in-
volved in the AZT excision process. The amino acid ex-
change S345T can be achieved by a single nucleotide
exchange (TCA >ACA). Therefore, moderately AZT re-
sistant virus is created very easily. This might be the rea-
son why the AZTMP removal pathway is favored over
AZTTP discrimination. The functions of the other ex-
changes are important to obtain highly resistant virus,
with improved fidelity and polymerization activity, com-
bined with recovered viral fitness. Thus, although HIV-1
and SFVmac achieve AZT resistance by removal of the in-
corporated AZTMP, the function of the resistance muta-
tions appear to be different.
Methods
Cloning, expression and protein purification
Construction of WT, mt3, and mt4 SFVmac PR-RTs was
published previously [14]. The single and double mu-
tants (Figure 2A) were created by site-directed mutagen-
esis according to the QuickChange protocol from
Stratagene (Heidelberg, Germany). Gene expression and
protein purification of all SFVmac PR-RT variants was
performed using published protocols [14].Table 3 Kinetic parameters for AZTMP removal by ATP in
SFVmac PR-RTs
Enzyme KM (μM) p-value Vmax (nM/min) p-value
S345T 811 (±127) 0.004 110.7 (±6.7) 0.02
mt2a 893 (±268) 0.011 112.4 (±14.7) 0.08
mt2c 899 (±73) 0.001 108.7 (±11.2) 0.06
mt3 142 (±44) 0.226 100.5 (±22.5) 0.14
mt4 241 (±101) - 131.2 (±5.6) -
The p-values were calculated with the unpaired t-test, each variant was compared
with the highly resistant mt4 variant. p-values ≤ 0.05 were considered significant.
Figure 7 Localization of tryptophan residues in RTshort mt4. A structure homology model was generated based on the structure of XMRV
RT (PDB: 4HKQ) using the Program SWISS-MODEL. Color coding is analogous to Figure 1. The Trp residues are highlighted in purple. (A) Ribbon
diagram and (B) space filling representation of the fingers and palm subdomains of mt4.
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for amino acid residues 107–368 of the PR-RT, were
cloned into the vector pET-GB1a (G. Stier, EMBL, Hei-
delberg, Germany), expressed as 6His-GB1a fusion pro-
teins, and purified as published previously for prototype
foamy virus (PFV) RNase H [43]. In brief, for 1H/15N
HSQC experiments, gene expression in Escherichia coli
Rosetta DE3 (Novagen/EMD Biosciences; Darmstadt,
Deutschland) was induced with 1 mM isopropyl-
thiogalactoside (IPTG) at an optical density at 600 nm
of 0.7 at 20°C in M9 medium supplemented with trace
element solution TS2 [44,45], 1 x MEM vitamin solu-
tion (Gibco, Karlsruhe, Germany), 1.5 g/l (15NH4)2SO4
(Cambridge Isotope laboratories, Inc., Andover, MA,
USA), and 2.5% of 15N labeled rich medium (Silantes,
Munich, Germany). In order to obtain 2H/15N- and 2H/
15N/13C- labeled RTshort-mt4 for the TROSY 1H/15N-
HSQC pre-cultures were grown as above or additionally
with 4 g/l 13C-glucose (Euriso-Top, GIF-SUR-YVETTE,
France), using a stepwise increase of D2O concentra-
tions from 50% and 75% up to a final concentration of
100%. After cell lysis the proteins were purified by
Ni-affinity chromatography. The 6His-GB1a-tag was
cleaved off by tobacco etch virus (TEV) protease and
the tag was removed using a second Ni-affinity chroma-
tography. The free RTshort variants were collected in
the flow through.
Quantitative polymerization assay
Measurements of RNA-dependent DNA polymerase ac-
tivity to determine the specific activity (SPAC) were car-
ried out on a poly(rA)/oligo(dT)15 substrate (0.2 U/ml)
(Roche Diagnostics GmbH, Mannheim, Germany) as dis-
cribed previously [14]. Under these conditions 1 unit (U)
of enzyme activity enables the incorporation of 1 nmol
TMP into poly(rA)/oligo(dT)15 after 10 min at 37°C.
To determine KM- and vmax- values, different dTTP
concentrations of 25, 50, 75, 125, 250, 600 μM were usedin the polymerization reactions and data were fitted to
the Michaelis-Menten equation (1) using the fitting pro-
gram GraFit 5.0.12 (Erithacus Software limited, West
Sussex, UK):
v ¼ vmax : dTTP½ 
KM þ dTTP½  ð1Þ
5′ endlabeling of primers
5′ 32P-endlabeling of the P30 primer (5′-GCTGTAATG
GCGTCCCTGTTCGGGCGCCTC) (biomers.net; Ulm,
Germany) as well as the corresponding AZTMP termi-
nated P30 primer (P30-AZTMP) was done as described pre-
viously [3,14].
Polymerization initiation reactions
Polymerization assays were performed using a 5′ 32P
endlabeled P30/T50 substrate (template 5′-GCTGTGGA
AAATCTCATGCAGAGGCGCCCGAACAGGGACGC
CATTACAGC), 250 μM of each dNTP and PR-RT as
described previously [4].
Qualitative RNase H assay
The RNA template (5′ AACAGAGUGCGACACCUG
AUUCCAU) (Metabion GmbH, Planegg-Martinsried,
Germany) was 32P-labeled at its 5′end and hybridized to
a DNA primer (5′ TGGAATCAGGTGTCGCACTCTG)
(Metabion GmbH, Planegg-Martinsried, Germany) using
a 1.2 fold excess of the DNA [3,14]. RNase H reactions
were performed with 240 nM RNA25/DNA22 hybrid and
50 nM RT-PR for 2 min at 25°C. Reactions were stopped
by the addition of an equal volume of urea loading buf-
fer (0.1% bromophenol blue, 0.1% xylene cyanol, 8 M
urea, 89 mM Tris/HCl pH 8.3, 89 mM boracic acid)
supplemented with 50 mM ethylenediaminetetraacetate
(EDTA). Reaction products were separated by denatur-
ing gel electrophoresis (10% polyacrylamide/8 M urea
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device (Dürr Medical CR 35 Bio; Bietigheim-Bissingen,
Germany) and quantified densitometrically with the soft-
ware AIDA Image Analyzer V.450 (raytest, Staubenhardt,
Germany).
Fluorescence equilibrium titrations
To determine dissociation constants (KD) for DNA bind-
ing, changes in anisotropy were measured by fluores-
cence equilibrium titrations with 5 nM of a 24/40-mer
DNA/DNA (primer 5′-ATCACCAGGAGAGGGGAAA
GCGGA, template 5′-DY647-CTAATTCCGCTTTCCC
CTCTCCTGGTGATCCTTTCCATCC) (biomers.net
GmbH, Ulm, Germany) and increasing amounts of en-
zyme at 25°C. KD-values were calculated via non-linear
curve fitting of the anisotropy data to a two component
binding equation as described previously [43].
AZTMP excision
The P30 DNA primer was terminated with AZTTP as
described [14]. Subsequently, the resulting P30-AZTMP
was purified via gel electrophoresis on a 20% denaturing
polyacrylamide/8 M urea gel followed by UV shadowing
to identify the DNA. After cutting out of the correct
band, the DNA was electro-eluted, dialyzed against H2O
and lyophilized. 100 pmoles of 5′- [32P] endlabeled P30-
AZTMP DNA were hybridized to a 1.2-fold molar excess
of the T50 template DNA as described [4,14]. 5 nM P30-
AZTMP/T50, 0.02 U of pyrophosphatase (Sigma-Aldrich
Chemie GmbH, Taufkirchen, Germany) and 5 mM ATP
(Jena Bioscience, Jena, Germany) were preincubated for
5 min at 37°C in reaction buffer in a total volume of
10 μl. AZTMP excision reactions were started by the
addition of 320 nM enzyme, carried out for 20 min at
37°C and stopped by adding 10 μl of urea loading buffer
with 25 mM EDTA. Reaction products were separated
by denaturing gel electrophoresis and quantified as de-
scribed above.
To determine the KM- and vmax-values for ATP exci-
sion identical conditions were applied. However, ATP
concentrations were varied, using 0.0, 0.15, 0.3, 0.5, 1.0,
2.0 or 3 mM ATP. KM- and vmax-values were obtained
using Hanes-Woolf linearization of the Michaelis-
Menten equation.
Polymerase fidelity measurements
A 50mer DNA template (T50dA) (5′- GCTGTGGCCG
GTCTCTTGTAGAGGCGCCCGAACAGGGACGCCA
TTACAGC) was hybridized to a 5′ 32P-labeled DNA
primer (P30) (5′-GCTCTAATGGCGTCCCTGTTCGG
GCGCCTC) (biomers.net; Ulm, Germany) [4]. 20 nM
of the T50dA/P30 substrate were pre-incubated for
2 min at 37°C with 0.08 U of pyrophosphatase (Sigma
Aldrich Chemie GmbH, Taufkirchen, Germany) and1.25 mM dATP (mismatch) or dTTP (match) in reac-
tion buffer. Reactions were started by the addition of
1.25 μM enzyme and stopped after 12 min with an
equal volume of urea loading buffer (see above). The
reaction products were separated via denaturing gel
electrophoresis (8% polyacrylamide/8 M urea gels) and
analyzed as described above. Since the bands above P31
all comprise the first correct dTTP incorporation they
were also included in quantification of the primer ex-
tensions. Mean values and standard deviations of at
least three independent experiments were analyzed in
unpaired t-tests. Significant differences to the WT en-
zyme are indicated as p-values in Additional file 1:
Table S1 and in Figure 4C by asterisks.
ATP binding experiments
2D [1H-15N] HSQC experiments were recorded in the
absence and presence of ATP (21 mM) (Jena Bioscience,
Jena, Germany) with RTshort-WT, RTshort-mt4 and
RTshort-mt4-T345S in binding buffer [50 mM Tris/HCl
pH 6.725°C, 150 mM NaCl, 6 mM MgCl2, 0.5 mM DTT]
with 10% (v/v) D2O at 298 K. To determine the
KD-value for ATP of RTshort-mt4, transverse relaxation-
optimized spectroscopy (TROSY) 1H/15N-HSQC experi-
ments [46,47] were done with 205 μM of deuterated and
15N labeled 2H/15N RTshort-mt4 in binding buffer. 1H
back-exchange of amide protons was achieved by over-
night dialysis of the protein against binding buffer at
4°C. Comparison with spectra of 15N-labeled protein
demonstrated the nearly complete back-exchange of
amide protons. A TROSY 1H/15N–HSQC spectrum of
RTshort-mt4 was recorded without ATP and after the
addition of ATP at various molar ratios as indicated in
Figure 6. The KD-values for ATP of seven different shift-
ing signals were determined by fitting the chemical shift
changes of the TROSY 1H/15N-HSQCs to a two-state
model (equation 2). δobs, δP and δPL are the chemical
shifts for the protein in the ATP-bound and -unbound
state, the free RTshort-mt4, and the ATP/RTshort-mt4
complex, respectively. [P0] is the total protein concentra-
tion and r describes the ration of ATP and protein con-
centration, [ATP]/[RTshort-mt4].
Δδobs ¼ δP þ δPL−δPð Þ⋅
KD þ 1þ rð Þ P0½ f g−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
KD þ 1−rð Þ P0½ f g2−4 P0½ 2r
q
2 P0½ 
2
4
3
5
ð2Þ
The mean KD-value with standard deviation was calcu-
lated using the independent fits of the seven shifting res-
idues. TROSY based triple resonance experiments [48]
were recorded for protein backbone assignment using a
2H/13C/15N labeled sample. All spectra were acquired
Schneider et al. Retrovirology  (2015) 12:21 Page 13 of 14on Bruker Avance 700 and 800 MHz spectrometers
equipped with cryogenically cooled probes. The NMR
data was processed applying in house protocols and
analyzed with the program NMRView (B. A. Johnson;
Merck, Whitehouse Station, NJ, USA).
Additional file
Additional file 1: Table S1. Fidelity of PR-RTs. Quantification of the
primer extension reactions with a templated (match) and non-templated
(mismatch) dNTP represented in Figure 3.
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